Bio-link Australia Pty. Ltd.

17th February 2010 – Bio-Link Engaged by QRxPharma

Bio-Link has been engaged by QRxPharma to assist in partnering the TorsinA Drug Discovery Program for Protein Misfolding Diseases. Lead indications are Parkinson’s disease and early-onset torsion dystonia. QRxPharma is the exclusive licensee of the Program, which is located at the University of Alabama.